Active monitoring for atrial fibrillation (AMALFI): a streamlined randomised controlled trial of remote screening for subclinical atrial fibrillation

16 April 2023 (09:20 - 09:30)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Rohan Wijesurendra

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail

Atrial fibrillation screening to prevent stroke in patients with high NT-proBNP - a post-hoc analysis of the randomized LOOP study

Doctor S. Diederichsen (Copenhagen, DK)

Abstract Slides Video

Presentation thumbnail

Atrial fibrillation is an independent risk factor for heart failure progression and pump failure mortality in HFpEF:: a propensity score matched analysis of the TOPCAT Americas study

Professor D. Shah (Geneva, CH)

Abstract Slides Video

Presentation thumbnail

Effects of antiarrhythmics on atrial high rate episodes and progression to clinical atrial fibrillation (ANTI-AHRE)

Doctor S. Simovic (Kragujevac, RS)

Abstract Slides Video

Presentation thumbnail

Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus

Doctor H. Ahn (Seoul, KR)

Abstract Slides Video

Presentation thumbnail

Atrial fibrillation and in-hospital mortality in Covid-19 patients

Doctor I. Kotadia (London, GB)

Abstract Slides Video

Access the full session

Session thumbnail

Atrial Fibrillation - Round 1 - Drugs, Prevention

The Event

Event poster

EHRA 2023

16 April 2023 09:20 CET

You may be interested in

Congress Presentation

AMALFI: Active Monitoring for Atrial Fibrillation

Congress Presentation

Discussant review - AMALFI

Congress Session

Ask the Trialists - AMALFI

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources